As a professional pharmaceutical manufacturer and reliable supplier in China, PURUI (Henan Purui Pharmaceutical) upholds the philosophy of "Technological Innovation, Exceptional Quality." Strictly adhering to GMP standards, and leveraging an integrated "API–Intermediate–Formulation" production layout, the company categorizes its pharmaceutical intermediates by application area to ensure that all products meet international standards.
Established in 2004 and headquartered in Henan, China, PURUI is a modern pharmaceutical enterprise integrating R&D, production, sales, and service. As a National High-tech Enterprise and a GMP-certified manufacturer, its 120,000-square-meter facility serves as a vital production hub for pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). Leveraging its core technologies, PURUI Pharmaceutical Intermediates are tailored to meet the specific requirements of anticholinergic and emergency-care APIs. Through rigorous quality control applied throughout the entire process, the company not only satisfies domestic demand but also establishes itself as a key export base for related pharmaceutical products in China.
As a core product category, PURUI’s anticholinergic pharmaceutical intermediates are specifically designed to complement the company’s leading anticholinergic APIs. Used in the synthesis of medications for both acute and chronic diseases, these intermediates boast advantages such as high purity, exceptional stability, and strong specificity, thereby guaranteeing the quality and yield of the final APIs.
These intermediates are manufactured in GMP-certified facilities using advanced equipment and in strict compliance with ICH Q7 guidelines. Representative products—such as Tropine, Tropinone, and Tropic Acid (CAS No.: 529-64-6)—have earned widespread recognition from clients both domestically and internationally. Supported by its affiliated engineering technology research centers, PURUI continuously optimizes its manufacturing processes to balance product performance with cost-efficiency, thereby demonstrating its technical authority within the industry.
Emergency-care intermediates constitute another core category, specifically tailored to support the production of APIs used in emergency medical settings. Characterized by rapid synthesis capabilities, high safety profiles, and consistent quality, these intermediates play a critical role in ensuring the reliable supply of life-saving emergency medications.
PURUI offers a comprehensive range of emergency-care pharmaceutical intermediates covering a wide variety of types and specifications. Utilizing advanced precision control technologies, the company’s R&D team continuously refines these products based on evolving clinical requirements. As a dedicated professional supplier, PURUI also provides concurrent technical support; furthermore, all products undergo rigorous testing to ensure full compliance with the stringent quality standards required for the production of emergency-care pharmaceuticals.
PURUI places the utmost importance on the quality of its Pharmaceutical Intermediates. We have established a comprehensive, end-to-end quality management system, and our manufacturing facilities are equipped with high-precision quality inspection equipment. This enables us to conduct thorough testing at every stage of the production process, ensuring full compliance with both national and international standards.
PURUI holds numerous certifications and qualifications—including GMP certification and recognition as a National High-Tech Enterprise—and engages in deep collaborative partnerships with renowned research institutions to continuously enhance the technological sophistication and quality stability of our intermediates. As a leading supplier in China, we have earned global recognition through our commitment to transparent management and rigorous quality control.
